Cognition therapeutics stock news
WebApr 12, 2024 · Cognition Therapeutics, Inc.'s (NASDAQ:CGTX) market cap surged US$46m last week, individual investors who have a lot riding on the company were … WebApr 9, 2024 · According to analysts' consensus price target of $9.50, Cognition Therapeutics has a forecasted upside of 400.0% from its current price of $1.90. Amount …
Cognition therapeutics stock news
Did you know?
WebCognition has identified several compounds that bind to a receptor that regulates key cellular processes that are impaired in several neurodegenerative diseases. Our lead … WebMar 21, 2024 · Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results Mar 16, 2024 Read More » Cognition Therapeutics Announces Development …
WebMar 17, 2024 · Cognition Therapeutics raised more than $45 million after IPO priced in the middle of the expected range Oct. 8, 2024 at 7:42 a.m. ET by Tomi Kilgore Cognition … WebOct 16, 2024 · Cognition Therapeutics is a privately held biopharmaceutical company developing a pipeline of disease modifying small molecule drug candidates to treat neurocognitive disorders.
WebView the latest CGTX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of COGNITION THERAPEUTICS, INC.. WebApr 10, 2024 · Volatility & Risk. Cognition Therapeutics has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, Cognition …
WebThe Cognition Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, …
WebMar 23, 2024 · Mar. 23, 2024 7:48 AM ET Cognition Therapeutics, Inc. (CGTX) By: Meghavi Singh, SA News Editor. Cognition Therapeutics press release ( NASDAQ: CGTX ): Q4 GAAP EPS of -$0.91 misses by $0.68. On ... lighthouse b \\u0026 b\\u0027s michiganWebApr 12, 2024 · Stock Market News. CGTX. Cognition Therapeutics Announces New Scientific Publication on Therapeutic Potential of Targeting Sigma-2 Receptor for Age … peach\u0027s castle interior modelWebNov 15, 2024 · PURCHASE, N.Y., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced the closing of its previously announced... peach\u0027s castle interiorWebCognition Therapeutics in the past 3 months CGTX Stock 12 Months Forecast $12.00 (506.06% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Cognition Therapeutics in the last 3 months. The average price target is $12.00 with a high forecast of $15.00 and a low forecast of $9.00. lighthouse b \u0026 bWebMar 22, 2024 · Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $50 Stocks Under $100 Alternative Investing Invest in Art Invest in Watches Invest in Land Invest in Real Estate Invest in Wine Invest... peach\u0027s castle lego instructionsWebCognition has identified several compounds that bind to a receptor that regulates the cellular damage response and have shown potential in the treatment of neurodegenerative diseases. lighthouse azureWebThe Cognition Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. lighthouse b and b\\u0027s